News | November 30, 2022
Briefs: Lupin and GMM Pfaudler
The joint venture will help both the parties to further develop the high-margin service business
The joint venture will help both the parties to further develop the high-margin service business
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
The product is expected to be launched by Q4 FY23.
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
Subscribe To Our Newsletter & Stay Updated
